Back to Search
MEGAN DURBIN, MD
MD
Surgery Physician
NPI: 1063699247Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Drug-regulatable cancer cell death induced by BID under control of the tissue-specific, lung cancer-targeted TTS promoter system.
PMID 19598260·Int J Cancer·2009
7-preclinical
Doubly diastereoselective conjugate addition of homochiral lithium amides to homochiral alpha,beta-unsaturated esters containing cis- and trans-dioxolane units.
PMID 19194592·Org Biomol Chem·2009
8-other
Malignant pleural mesothelioma-targeted CREBBP/EP300 inhibitory protein 1 promoter system for gene therapy and virotherapy.
PMID 18757427·Cancer Res·2008
7-preclinical
Fetal oxygen saturation after combined spinal-epidural labor analgesia: a case series.
PMID 17967682·J Clin Anesth·2007
8-other
Pulmonary adenocarcinoma-targeted gene therapy by a cancer- and tissue-specific promoter system.
PMID 17237283·Mol Cancer Ther·2007
7-preclinical
Development of a novel beta-cell specific promoter system for the identification of insulin-producing cells in in vitro cell cultures.
PMID 16934249·Exp Cell Res·2006
7-preclinical
Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene.
PMID 16895524·Biochem J·2006
8-other
The relative roles of three DNA repair pathways in preventing Caenorhabditis elegans mutation accumulation.
PMID 16783005·Genetics·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1375 FRIAR LN
COLUMBUS, OH 43221 - Phone
- (614) 404-0180
Quick Facts
- NPI
- 1063699247
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile